From: Cabrol procedure and its modifications: a systematic review and meta-analysis
Variables | Pooled Data | Data Range | Included Studies (N) |
---|---|---|---|
Total patient number | 833 | 15–260 | 14 |
Surgical period | 1973–2020 |  | 14 |
Mean age, y | 50.8 | 42.5–60 | 12 |
Sex (%) | |||
 Male | 68.0 | 13–84 | 7 |
Comorbidity (%) | |||
 Connective tissue disease  Bicuspid aortic valve  Coronary heart disease  Hypertension  Annuloaortic ectasia  Atherosclerotic aneurysm  Poststenotic dilatation | 27.7 16.4 20.9 45.5 55.2 12.9 9.4 | 2–47 3–8 4–23 11–22 10–68 3–5 3–5 | 7 3 2 3 3 2 2 |
Previous operation (%) | 34.5 | 3–62 | 8 |
Type A dissection (%) Acute | 42.2 14.0 | 8–56 5–12 | 6 6 |
Endocarditis (%) | 13.0 | 1–12 | 3 |
Emergency operation (%) | 28.0 | 1–21 | 5 |
Surgical data | |||
 Cardiopulmonary bypass time  Aortic cross-clamp time | 192.7 137.5 | 126–247 91–186 | 5 5 |
Cabrol types (%) | |||
 Classic  Modified  Cabrol fifistula  Mechanical prosthesis  Bio-prosthesis | 80.7 19.3 64.0 85.2 11.3 | 6-212 18–84 0-212 25–69 0–13 | 14 14 7 5 5 |
Concomitant procedures (%) | |||
 Aortic arch repair  CABG  Mitral valve operation | 18.5 4.3 3.9 | 3–25 1–6 1–4 | 4 5 3 |
Reexploration for bleeding (%) | 4.9 | 0–6 | 7 |
Early mortality (%) | 9.0 | 0–13 | 10 |